Overall, only minor growth inhibition was observed for Braf mutant mouse and human colorectal cancer cell lines treated with 5 μM PLX4720, a selective inhibitor of mutant Braf (Figures 7A and 7B). Here, BRAF is linked to colorectal cancer.